SCHEMBL856105

SCHEMBL856105

CCCNC(=O)n1ccc2c(C=O)cccc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ERN1 O75460 1/20 0.39
ASAH1 Q13510 1/20 0.38
NOTUM Q6P988 1/20 0.38
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
ALDH1A1 P00352 1/20 0.36
S1PR1 P21453 1/20 0.36
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL414552 0.92 ASAH1 (0.44) BCHEASAH1ALDH1A1S1PR1HTT
SCHEMBL9854713 0.77 NOTUM (0.61) ERN1NOTUMALDH1A1MEN1KMT2A
Butyramide SCHEMBL28013718 0.75 NOTUM (0.37) NOTUMPDCD1CD274ALDH1A1MEN1
SCHEMBL8688017 0.73 ALDH1A1 (0.47) ALDH1A1MEN1HTTKMT2ASMN1; SMN2
SCHEMBL20905239 0.72 NOTUM (0.40) NOTUMALDH1A1
SCHEMBL8685355 0.71 L3MBTL1 (0.55) NOTUMPDCD1CD274ALDH1A1KMT2A
SCHEMBL31668328 0.71 L3MBTL1 (0.55) NOTUMPDCD1CD274ALDH1A1KMT2A
SCHEMBL8686727 0.70 APP (0.40) BCHENOTUMPDCD1CD274ALDH1A1
SCHEMBL1760744 0.70 MEN1 (0.43) BCHENOTUMALDH1A1MEN1KMT2A
SCHEMBL29955958 0.69 ALDH1A1 (0.43) ALDH1A1MEN1HTTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed